XPAR
OR
Market cap232bUSD
Sep 17, Last price
380.10EUR
1D
-0.47%
1Q
0.00%
Jan 2017
119.20%
Name
L'Oreal SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
L'Oréal S.A., a leading global beauty enterprise, manufactures and markets a comprehensive array of cosmetic items for male and female consumers across the globe, operating through its subsidiaries. The company structures its vast operations into four primary segments: Consumer Products, L'Oréal Luxe, Professional Products, and Active Cosmetics. Its diverse product portfolio encompasses hair care (including shampoos, styling aids, and colorants), skin care (cleansers, moisturizers, sun protection), body care (shower gels, deodorants), an extensive make-up range, and various fragrances. L'Oréal owns a vast collection of well-known brands, such as L'Oréal Paris, Garnier, Maybelline New York, Lancôme, Yves Saint Laurent Beauté, Kiehl's, Vichy, La Roche-Posay, and CeraVe, among numerous others, catering to a wide spectrum of market demands. These offerings are distributed through a broad global network, including professional hair salons, mass-market retail outlets, high-end perfumeries, department stores, pharmacies, drugstores, medispas, dedicated branded stores, travel retail locations, and robust e-commerce platforms. Established in 1909, L'Oréal S.A. is headquartered in Clichy, France.
Related entities
Subsidiaries (60)
L'OREAL ESPANA SA
L'Oreal Hong Kong Limited
L'OREAL INDIA PRIVATE LIMITED
L'Oreal Israel Cosmetics Ltd.
L'OREAL ITALIA S.P.A.
L'Oreal Liban S.A.L.
L'OREAL LIBRAMONT
L'OREAL Magyarország Kozmetikai Kft.
L'OREAL MALAYSIA SDN. BHD.
L'OREAL NEW ZEALAND LIMITED
L'OREAL NORGE AS
L'Oreal Philippines, Inc.
L'OREAL ROMANIA SRL
L'OREAL SINGAPORE PTE. LTD.
L'OREAL SLP S.A. DE C.V.
L'OREAL SUISSE SA
L'OREAL TRAVEL RETAIL AMERICAS, INC.
L'OREAL TÜRKİYE KOZMETİK SANAYİ VE TİCARET ANONİM ŞİRKETİ
L'OREAL USA, INC.
L'OREAL Österreich GmbH
Key people
Chairman of the Board and Chief Executive Officer, Member of the Executive Committee · since 2011
Vice Chairman of the Board · since 2017
Laurent Attal
Executive Vice President - Research & Innovation, Member of the Executive Committee · since 2010
Lucia Dumas Bezian
Executive Vice President - Communication and Public Affairs, Member of the Executive Committee · since 2018
Chief Financial Officer, Executive Vice President, Member of the Executive Board · since 2019
Fabrice Megarbane
President L'Oreal China, Member of the Executive Committee · since 2019
Executive Vice President, Chief Digital Officer, Member of the Executive Committee · since 2014
Ana Sofia Amaral
Director - Employee Representative · since 2014
Francoise Bettencourt Meyers
Director · since 1997
Georges Liarokapis
Director - Employee Representative · since 2014
Independent Director · since 2015
Independent Director · since 2018
Fabienne Dulac
Independent Director · since 2019
Eileen Naughton
Independent Director · since 2016
Headquarters & legal address
14 RUE ROYALE
PARIS 75008
FR
PARIS 75008
FR
Trading name
KERASTASE ; MIZANI ; L'OREAL PROFESSIONNEL PARIS ; ESSIE PROFESSIONNEL ; BAXTER OF CALIFORNIA ; BIOL
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||